Accelerating Order Intake
Signed approximately $2.0 billion of orders year-to-date (double the amount signed through the same period last year, ~+100% YTD). Q3-to-date bookings exceed $600 million. Management expects total fiscal 2026 order intake to significantly exceed fiscal 2025.
Record Backlog
Record backlog of $5.6 billion at the end of Q2 2026, providing strong revenue visibility into the remainder of the fiscal year.
Improving Margins and Margin Durability
Q2 adjusted gross margin was 11.1% (within full-year guidance of 11%–13%) with rolling 12-month adjusted gross margin at 12.4%, reflecting two years of consistent double-digit adjusted gross margins.
Reaffirmed Fiscal 2026 Guidance
Reaffirmed revenue guidance of $3.2B–$3.6B (midpoint $3.4B), ARR target of ~ $180M (up from $148M in FY2025, +21.6%), and adjusted EBITDA guidance of $40M–$60M for the full year.
Strong Liquidity Position
Ended Q2 with approximately $900 million total liquidity, including ~$430 million in cash. Management expects liquidity to return to ~$900M by fiscal year-end after planned inventory investments.
Hyperscaler Wins and New Customer Expansion
Executed master supply agreements (MSAs) with two major hyperscalers after rigorous technical and commercial qualification. 50% of orders this year are from new customers, signaling expanding addressable market reach.
Product and Supply-Chain Milestones (Smartstack & U.S. Supply)
First Smartstack system reached substantial completion and commenced commercial operations; Smartstack enables >500 MWh per acre density and >98% reliability. Full U.S. domestic production for major components (including cell supplier in Smyrna, TN) and an additional U.S. cell source contracted to begin in fiscal 2027.
Adjusted EBITDA and Operational Improvement
Q2 adjusted EBITDA was negative $9M, an improvement of $21M versus Q2 of last year, driven by higher gross margin, lower operating costs and a $6M FX derivative gain.